M 1121 is a potent, orally bioavailable small molecule inhibitor that disrupts the menin-MLL protein-protein interaction. It demonstrates robust anti-tumor activity in preclinical models, achieving complete and durable regression in vivo, and is a key research tool for studying MLL-rearranged leukemias.
Molekulargewicht:
793.01
CAS Nummer:
[2377337-93-2]
Formel:
C42H57FN6O6S
Target-Kategorie:
Others,Epigenetic Reader Domain
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
